RTP company to work with Johns Hopkins and Tufts on diagnostic of 'silent killer'
Research Triangle Park metabolomics developer Metabolon has reached a deal with two health care titans to develop a new tool to help in diagnosing chronic kidney disease.
Kidney disease can be caused by diabetes, a growing epidemic worldwide, and a diagnostic test to better identify early stages of kidney disease – when it is still treatable – could serve a valuable role.
Metabolon reached the deal with Johns Hopkins University and Tufts Medical Center to develop a test that will require just…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Jason deBruyn Source Type: news
More News: Chronic Kidney Disease | Diabetes | Endocrinology | Epidemics | Epidemiology | Health | Health Management | John Hopkins University | Pharmaceuticals | Urology & Nephrology